01 1Zhejiang Huahai Pharmaceutical
01 1CITALOPRAM HYDROBROMIDE USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-08-15
Pay. Date : 2023-08-11
DMF Number : 20586
Submission : 2007-06-04
Status : Active
Type : II
20
Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CITALOPRAM HYDROBROMIDE USP, with a corresponding US DMF Number 20586.
Remarkably, this DMF maintains an Active status since its submission on June 04, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 15, 2023, and payment made on August 11, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
